On October 7, 2024, James Clemmer, President and Chief Executive Officer of AngioDynamics Inc (ANGO, Financial), purchased 20,000 shares of the company. Following this transaction, the insider now owns a total of 681,582 shares. Details of the transaction can be viewed on the SEC Filing.
AngioDynamics Inc specializes in the development, manufacture, and sale of medical, surgical, and diagnostic devices. These products aim to enhance the quality of patient care in the vascular and oncology sectors.
Over the past year, James Clemmer has increased his holdings in the company by purchasing a total of 30,000 shares, with no recorded sales of shares during this period. The insider transaction history for AngioDynamics Inc shows a trend of more insider buying than selling, with 2 insider buys and 0 insider sells over the past year.
Shares of AngioDynamics Inc were priced at $6.03 on the day of the insider's recent purchase. The company has a market cap of approximately $238.93 million.
The stock's valuation metrics, such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, are calculated based on historical trading multiples, adjustments for past performance, and future business projections. According to the GF Value, the stock is currently undervalued with a price-to-GF-Value ratio of 0.66, indicating it is a possible value trap and investors should think twice.
This insider buying activity could signal a positive outlook from the insider regarding the company's future performance, despite the current valuation suggesting caution.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
